Relmada Therapeutics (NasdaqGS:RLMD) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Company ParticipantsBrian Ritchie - Managing DirectorSergio Traversa - CEOBipin Dalmia - Chief Business OfficerMaged Shenouda - CFOConference Call ParticipantsKelsey Goodwin - Director and Senior Research AnalystAndres Maldonado - Senior Biotechnology AnalystFarzin Haque - Senior Vice President and Biotechnology Equity Research AnalystNone - AnalystOperatorGood afternoon, and welcome to the Relmada Therapeutics Third Qu ...